Literature DB >> 27771785

Psychometric properties and measurement equivalence of the English and Chinese versions of the Beck Anxiety Inventory in patients with breast cancer.

Yu Ke1, Terence Ng1, Hui Ling Yeo1, Maung Shwe1, Yan Xiang Gan2, Alexandre Chan3,4,5.   

Abstract

BACKGROUND: There is a lack of psychometric data for both the English and Chinese versions of Beck Anxiety Inventory (BAI) to support its usage among breast cancer patients. This study examined the psychometric properties and measurement equivalence of the English and Chinese versions of BAI among breast cancer patients in Singapore.
METHODS: Patients were recruited from two major cancer centers in Singapore. The criterion and construct validity of BAI was assessed by its correlation strength with (1) the emotional functioning subdomain of EORTC QLQ-C30 and (2) constructs related to anxiety, namely fatigue, dyspnea, and quality of life. The known-group validity was assessed according to the patients' breast cancer stage, religious beliefs, and emotional functioning levels. The internal consistency of the BAI domains was evaluated using Cronbach's alpha coefficient. Regression analysis was performed to compare the BAI total and domain scores between the two language versions.
RESULTS: Data from 244 patients (144 English-speaking and 100 Chinese-speaking) were analyzed. For both language versions, the BAI total scores correlated moderately with the EORTC QLQ-C30 emotional functioning subdomain (r = -0.655 and -0.601). Correlations with fatigue, quality of life, and dyspnea were moderate (|r| = 0.456-0.606). Patients with poorer emotional functioning reported higher anxiety levels, establishing known-group validity. All BAI domains demonstrated satisfactory internal consistencies (α = 0.74-0.87), except for the panic domain (α = 0.57-0.61). Possible measurement equivalence between the language versions was established.
CONCLUSION: Both English and Chinese versions of BAI are valid, reliable, and possibly equivalent for future use.

Entities:  

Keywords:  Anxiety; Beck anxiety inventory; Cancer; Measurement equivalence; Oncology; Validation

Mesh:

Year:  2016        PMID: 27771785     DOI: 10.1007/s00520-016-3452-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  41 in total

Review 1.  Monotherapy comparative trials: equivalence and differences in clinical trials.

Authors:  D Chadwick
Journal:  Epilepsy Res       Date:  2001-05       Impact factor: 3.045

2.  Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients.

Authors:  N Kontodimopoulos; K Ntinoulis; D Niakas
Journal:  Eur J Cancer Care (Engl)       Date:  2011-05       Impact factor: 2.520

3.  Religious commitment, religious coping and anxiety: a study in German patients with breast cancer.

Authors:  C Zwingmann; C Müller; J Körber; S Murken
Journal:  Eur J Cancer Care (Engl)       Date:  2008-07       Impact factor: 2.520

4.  The Beck Anxiety Inventory: reexamination of factor structure and psychometric properties.

Authors:  A Osman; B A Kopper; F X Barrios; J R Osman; T Wade
Journal:  J Clin Psychol       Date:  1997-01

5.  An inventory for measuring clinical anxiety: psychometric properties.

Authors:  A T Beck; N Epstein; G Brown; R A Steer
Journal:  J Consult Clin Psychol       Date:  1988-12

6.  Trials to assess equivalence: the importance of rigorous methods.

Authors:  B Jones; P Jarvis; J A Lewis; A F Ebbutt
Journal:  BMJ       Date:  1996-07-06

7.  Respiratory disorders as a possible predisposing factor for panic disorder.

Authors:  K Verburg; E Griez; J Meijer; H Pols
Journal:  J Affect Disord       Date:  1995-02-21       Impact factor: 4.839

8.  Exploring clinical determinants and anxiety symptom domains among Asian breast cancer patients.

Authors:  Yin Ting Cheung; Helen Hoi-Lun Lee; Alexandre Chan
Journal:  Support Care Cancer       Date:  2013-03-09       Impact factor: 3.603

Review 9.  Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A).

Authors:  Laura J Julian
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

10.  Reassurance and the anxious cancer patient.

Authors:  D Stark; M Kiely; A Smith; S Morley; P Selby; A House
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

View more
  7 in total

1.  Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study.

Authors:  Terence Ng; Ying Yun Lee; Jung-Woo Chae; Angie Hui Ling Yeo; Maung Shwe; Yan Xiang Gan; Raymond C H Ng; Pat Pak Yan Chu; Chiea Chuen Khor; Han Kiat Ho; Alexandre Chan
Journal:  BMC Cancer       Date:  2017-12-19       Impact factor: 4.430

2.  Association of plasma leptin, pro-inflammatory adipokines and cancer-related fatigue in early-stage breast cancer patients: A prospective cohort study.

Authors:  Yi Long Toh; Chia Jie Tan; Angie Hui Ling Yeo; Maung Shwe; Han Kiat Ho; Yan Xiang Gan; Koon Mian Foo; Pat Chu; Karin Olson; Alexandre Chan
Journal:  J Cell Mol Med       Date:  2019-04-23       Impact factor: 5.310

Review 3.  What are the optimal measures to identify anxiety and depression in people diagnosed with head and neck cancer (HNC): a systematic review.

Authors:  Chindhu Shunmugasundaram; Claudia Rutherford; Phyllis N Butow; Puma Sundaresan; Haryana M Dhillon
Journal:  J Patient Rep Outcomes       Date:  2020-04-23

4.  Reducing severe fatigue in patients with diffuse glioma: a study protocol for an RCT on the effect of blended cognitive behavioural therapy.

Authors:  Jantine Geertruida Röttgering; Linda Douw; Philip C de Witt Hamer; Mathilde C M Kouwenhoven; Tom Würdinger; Peter M van de Ven; Louise Sharpe; Hans Knoop; Martin Klein
Journal:  Trials       Date:  2022-07-15       Impact factor: 2.728

5.  Effects of relaxation therapy on maternal psychological state, infant growth and gut microbiome: protocol for a randomised controlled trial investigating mother-infant signalling during lactation following late preterm and early term delivery.

Authors:  Jinyue Yu; Jonathan Wells; Zhuang Wei; Mary Fewtrell
Journal:  Int Breastfeed J       Date:  2019-12-16       Impact factor: 3.461

6.  Analysis of anxiety-related factors amongst frontline dental staff during the COVID-19 pandemic in Yichang, China.

Authors:  Suli Zhao; Jing Cao; Rongcan Sun; Lin Zhang; Beibei Liu
Journal:  BMC Oral Health       Date:  2020-11-26       Impact factor: 2.757

7.  Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment.

Authors:  Ning Yi Yap; Yi Long Toh; Chia Jie Tan; Munjal M Acharya; Alexandre Chan
Journal:  Cytokine       Date:  2021-05-10       Impact factor: 3.861

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.